Stockreport

IBN Coverage: Clene (NASDAQ: CLNN) Positioned as Leader in Addressing Neurodegenerative Diseases [Yahoo! Finance]

Clene Inc.  (CLNN) 
PDF LOS ANGELES, CA - ( NewMediaWire ) - September 3, 2024 - Clene (NASDAQ: CLNN) , a biopharmaceutical company, is at the forefront of transforming the treatment of neurod [Read more]